ATE414717T1 - Neuromedin u delta polypeptide - Google Patents
Neuromedin u delta polypeptideInfo
- Publication number
- ATE414717T1 ATE414717T1 AT01967314T AT01967314T ATE414717T1 AT E414717 T1 ATE414717 T1 AT E414717T1 AT 01967314 T AT01967314 T AT 01967314T AT 01967314 T AT01967314 T AT 01967314T AT E414717 T1 ATE414717 T1 AT E414717T1
- Authority
- AT
- Austria
- Prior art keywords
- neuromedin
- polypeptides
- delta polypeptides
- delta
- polynucleotides
- Prior art date
Links
- 229920001184 polypeptide Polymers 0.000 title abstract 4
- 108090000765 processed proteins & peptides Proteins 0.000 title abstract 4
- 102000004196 processed proteins & peptides Human genes 0.000 title abstract 4
- RWBLWXCGQLZKLK-USVTTYPOSA-N (2s)-2-[(2-aminoacetyl)amino]-n-[(2s)-1-[[(2s)-1-[[(2s)-1-[[(2s)-1-[[2-[[(2s)-1-[[(2s)-1-[[(2s)-1-amino-4-methylsulfanyl-1-oxobutan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-3-(1h-imidazol-5-yl)-1-oxopropan-2-yl]amino]-2-oxoethyl]amino]-3-methyl-1-oxob Chemical compound C([C@@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(N)=O)NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CC=1C2=CC=CC=C2NC=1)NC(=O)[C@H](CC=1NC=NC=1)NC(=O)[C@H](CC(N)=O)NC(=O)CN)C(C)C)C1=CN=CN1 RWBLWXCGQLZKLK-USVTTYPOSA-N 0.000 title 1
- 102100038813 Neuromedin-U Human genes 0.000 abstract 2
- 238000000034 method Methods 0.000 abstract 2
- 108010021512 neuromedin U Proteins 0.000 abstract 2
- 108091033319 polynucleotide Proteins 0.000 abstract 2
- 102000040430 polynucleotide Human genes 0.000 abstract 2
- 239000002157 polynucleotide Substances 0.000 abstract 2
- 238000003556 assay Methods 0.000 abstract 1
- 238000010188 recombinant method Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Zoology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- General Health & Medical Sciences (AREA)
- Toxicology (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Gastroenterology & Hepatology (AREA)
- Endocrinology (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Plant Substances (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP00122552 | 2000-10-16 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE414717T1 true ATE414717T1 (de) | 2008-12-15 |
Family
ID=8170105
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT01967314T ATE414717T1 (de) | 2000-10-16 | 2001-09-06 | Neuromedin u delta polypeptide |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20040073003A1 (de) |
| EP (1) | EP1330475B1 (de) |
| JP (1) | JP2004511252A (de) |
| AT (1) | ATE414717T1 (de) |
| AU (2) | AU2001287714B2 (de) |
| CA (1) | CA2425723A1 (de) |
| DE (1) | DE60136643D1 (de) |
| WO (1) | WO2002032937A2 (de) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPWO2008029601A1 (ja) * | 2006-08-16 | 2010-01-21 | 株式会社 未来創薬研究所 | ニューロメジンu受容体2(fm4)分子に対するリガンドを有効成分として含む癌治療剤 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1990001330A1 (en) * | 1988-08-11 | 1990-02-22 | Terence Bennett | Use of neuromedins u8 and u25 as therapeutic compounds |
| US6274720B1 (en) * | 1997-12-31 | 2001-08-14 | Incyte Genomics, Inc. | Human preproneurotensin/neuromedin N |
| US6461836B1 (en) * | 1999-11-05 | 2002-10-08 | Smithkline Beecham Corporation | Molecular cloning of a 7TM receptor (AxOR34) and screening methods thereof |
-
2001
- 2001-09-06 AT AT01967314T patent/ATE414717T1/de not_active IP Right Cessation
- 2001-09-06 US US10/398,650 patent/US20040073003A1/en not_active Abandoned
- 2001-09-06 AU AU2001287714A patent/AU2001287714B2/en not_active Ceased
- 2001-09-06 JP JP2002536318A patent/JP2004511252A/ja active Pending
- 2001-09-06 DE DE60136643T patent/DE60136643D1/de not_active Expired - Fee Related
- 2001-09-06 CA CA002425723A patent/CA2425723A1/en not_active Abandoned
- 2001-09-06 AU AU8771401A patent/AU8771401A/xx active Pending
- 2001-09-06 EP EP01967314A patent/EP1330475B1/de not_active Expired - Lifetime
- 2001-09-06 WO PCT/EP2001/010300 patent/WO2002032937A2/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| DE60136643D1 (de) | 2009-01-02 |
| JP2004511252A (ja) | 2004-04-15 |
| CA2425723A1 (en) | 2002-04-25 |
| WO2002032937A2 (en) | 2002-04-25 |
| AU8771401A (en) | 2002-04-29 |
| AU2001287714B2 (en) | 2006-10-26 |
| EP1330475B1 (de) | 2008-11-19 |
| WO2002032937A3 (en) | 2002-08-15 |
| EP1330475A2 (de) | 2003-07-30 |
| US20040073003A1 (en) | 2004-04-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO2001004141A3 (de) | Seripancrin | |
| AU8394601A (en) | A novel member of the epha receptor family | |
| WO2001083744A3 (en) | Natrium-calcium exchanger protein | |
| ATE319739T1 (de) | Menschliche wingless-änhliche gene | |
| DE60136643D1 (de) | Neuromedin u delta polypeptide | |
| DK1257573T3 (da) | Hidtil ukendt transskriptionsfaktor CARP-2 | |
| EP0890646A3 (de) | Serine-Protease HE2NW40 | |
| WO2001083771A3 (en) | Human phospholipase c delta 5 | |
| WO2001068816A8 (en) | Human histamine h3 gene variant-3 | |
| WO2001083768A3 (en) | Serine-threonine kinase | |
| NO20016340L (no) | Hodetraumeindusert cytoplasmatisk kalsiumbindende protein | |
| WO2002014355A3 (en) | Novel mitogen activated kinase | |
| DK1266008T3 (da) | Akut neuroninduceret calciumbindende protein type 1-ligand | |
| WO2001079269A3 (en) | Lipid binding protein 4 | |
| WO2001055428A3 (en) | Mprot45 metalloprotease | |
| WO2001055338A3 (en) | 7tm receptor axor51 | |
| ATE329025T1 (de) | Mfq-111, ein menschliches gtpase-ähnlichers protein | |
| EP0969091A3 (de) | Leptinrezeptorgenähnliches Protein | |
| WO2001085937A3 (en) | Regulator of g protein signalling (rgs8) | |
| WO2001077147A3 (en) | New bromodomain protein | |
| WO2002074796A3 (en) | Histidine phosphatase interacting protein with 240kd | |
| WO2001079492A3 (en) | Lipid binding protein 3 | |
| WO2002008252A3 (en) | Novel protein containing ring finger domaine r1p4 | |
| DE60041074D1 (de) | Spleissvariante des kopftrauma induzierten zytopla | |
| WO2001072963A3 (en) | Novel human uridine kinase |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |